Gernandt & Danielsson has advised in ADDvise Group AB’s (publ) (“ADDvise") issuance of corporate bonds in a total amount of USD 60 million and the partial redemption of ADDvise's existing bonds 2023/2026 conducted in connection therewith. The bonds have been admitted to trading on Nasdaq Stockholm.

ADDvise is an international life science group. Operating a decentralised ownership model, ADDvise develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market.

Gernandt & Danielsson has advised ADDvise with a team consisting of partner Mikael Borg and senior associate Jakob Forsell as well as associates Mathilda Wallén and Einar Brunsberg.